Room 810, 8F, No. 780, Cailun Road, Pudong New Area, Shanghai, China.
About us
Puheng Biomedicine (Shanghai) Co., Ltd.
Puheng Biomedicine (Shanghai) Co., Ltd is an innovative enterprise focused on the research and development and application of novel in vitro 3D organ/disease models, including complex 3D models such as NAC-Organ, organoids, organ-on-a-chip, etc. The company's independently developed NAC-Organ technology is the world's first assembly-based in vitro 3D model construction and culture technique based on nano-nucleic acid materials, capable of rapidly achieving high-throughput, standardized production of humanized complex organ/disease models. The company has established modeling techniques for common chronic diseases with chronic liver disease as a characteristic, various tumors, important physiological organs...
-
Development of in vitro 3D complex disease models
-
Drug screening based on in vitro 3D models
-
Development of Regenerative medicine technology
PUHENG has accumulated thousands of experimental data to provide you with reliable products and services.
MORE
Leading technological innovation and industrial transformation
-
NAC-linker is a Cell junction material developed by PUHENG Technology based on Synthetic biology technology.It enables efficient self-assembly of cells in a three-dimensional space and allows precise control over cell types, quantities, and spatial distri
-
Our NAC-Organ technology allows for the preparation of a 3D liver model (NAC-Liver) containing hepatocytes and non-parenchymal cells within 24 hours. NAC-Liver can be stably cultured in vitro for over 30 days, maintaining high levels of hepatocyte secreti
-
The automated cultivation system developed for NAC-organ enables high-throughput automated cultivation and testing of 3D models, ensuring standardization of the models and reproducibility of the test results. By utilizing high-content imaging systems, hig
Industry News
News Center
文献分享 | 利用人诱导多能干细胞构建同时含胆管和血管的肝类器官
人诱导多能干细胞（hiPSCs）技术已成功用于开发由胆管细胞组成的囊性结构，模拟肝内胆管（IHBD）。考虑到血管与胆管相互作用对肝内胆管发育的重要性，开发一种围绕血管重建人类胆管的体外方法对理解人类新生儿胆管结构异常形成的机制至关重要。 日本东京大学理化学研究所的Hideki Taniguchi教授团队近期在《Nature Communications 》发表了题为《Generation of human iPSC-derived 3D bile duct within ...
朴衡最新成果：利用NAC-Organ 3D 培养技术平台加速CAR-Macrophage细胞的高通量体外筛选
CAR-T细胞、TILs细胞等免疫细胞治疗方法作为一种新兴的治疗手段在肿瘤治疗领域展现出了巨大潜力，目前免疫细胞治疗方法在药效评估方面存在一些局限性，人源化体外3D培养模型通过减少动物实验和利用人源性组织，避免了物种差异带来的偏差，特别适用于患者特异性的肿瘤研究和传染病机制探索，为抗肿瘤药物研发提供更高效、更精准的研发工具。此外，体外3D培养技术可以构建多器官系统和长期培养，为研究药物在多个器官间的相互...
文献解读 | Nature 重大突破！构建具有组织驻留免疫细胞的人肠道类器官
肠道粘膜免疫系统-人体最大的免疫细胞库-对维持肠道稳态和预防肠道疾病等方面发挥重要作用，但目前的肠道类器官只能模拟上皮细胞类型的分化和功能，在捕捉肠道（病理）生理学的关键方面存在不足，原因是缺乏特定组织的免疫细胞群。近日，瑞士人类生物学研究所(IHB)发表最新研究，成功构建出人类肠道免疫类器官(IIOs)。该模型包含人体组织样本中的组织驻留和自体免疫细胞群，基于该模型文章探讨了自体组织驻留记忆T (TRM)细胞...
文献分享 | 利用人类多能干细胞模拟人类骨骼发育
遗传性骨骼疾病一直以来都是重大的疾病负担，但针对这类骨骼疾病的分子机制探究较少且手段有限，导致缺乏有效的治疗方法。体外疾病模型系统有助于理解其分子病理学和寻找治疗方案，但目前不存在能真实地重现软骨成熟和骨形成所有步骤的模型系统。而人多能干细胞（hPSCs）的分化为研究人类发育提供了独特平台，但要模拟复杂组织和疾病的起源，必须了解支撑谱系特异性分化的发育回路。 针对这一问题，2022年6月5日，澳大利亚默多克...
文献分享 | 利用类器官巨噬细胞共培养模型精准模拟多组织药物反应
随着体外药物测试在生物医学研究中的重要性日益增加，如何准确模拟不同细胞类型之间的相互作用成为一大挑战。鉴于上述挑战，韩国毒理学研究所的Han-Jin Park 教授团队近日在《Biofabrication》上发表了题为《hiPSC-derived macrophages improve drug sensitivity and selectivity in a macrophage-incorporating organoid culture model》的论文，该研究将人类诱导性多能干细胞（hiPSC）
